OA12101A - Antipicornaviral compounds and compositions, theirpharmaceutical uses, and materials for their synt hesis. - Google Patents
Antipicornaviral compounds and compositions, theirpharmaceutical uses, and materials for their synt hesis. Download PDFInfo
- Publication number
- OA12101A OA12101A OA1200200160A OA1200200160A OA12101A OA 12101 A OA12101 A OA 12101A OA 1200200160 A OA1200200160 A OA 1200200160A OA 1200200160 A OA1200200160 A OA 1200200160A OA 12101 A OA12101 A OA 12101A
- Authority
- OA
- OAPI
- Prior art keywords
- group
- pharmaceutically acceptable
- compound
- substituted
- heterocycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16898699P | 1999-12-03 | 1999-12-03 | |
| US19205200P | 2000-03-24 | 2000-03-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA12101A true OA12101A (en) | 2006-05-04 |
Family
ID=26864652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA1200200160A OA12101A (en) | 1999-12-03 | 2000-12-01 | Antipicornaviral compounds and compositions, theirpharmaceutical uses, and materials for their synt hesis. |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US6514997B2 (ru) |
| EP (1) | EP1252145A1 (ru) |
| JP (1) | JP2003515591A (ru) |
| KR (1) | KR20020058076A (ru) |
| CN (1) | CN1402710A (ru) |
| AP (1) | AP2002002510A0 (ru) |
| AR (1) | AR030540A1 (ru) |
| AU (1) | AU777943B2 (ru) |
| BG (1) | BG106754A (ru) |
| BR (1) | BR0016742A (ru) |
| CA (1) | CA2392504A1 (ru) |
| CO (1) | CO5261566A1 (ru) |
| CZ (1) | CZ20021906A3 (ru) |
| DO (1) | DOP2000000108A (ru) |
| EA (1) | EA200200625A1 (ru) |
| EE (1) | EE200200281A (ru) |
| HK (1) | HK1052933A1 (ru) |
| HU (1) | HUP0204006A3 (ru) |
| IL (1) | IL149427A0 (ru) |
| IS (1) | IS6378A (ru) |
| MX (1) | MXPA02005124A (ru) |
| NO (1) | NO20022589L (ru) |
| NZ (1) | NZ518934A (ru) |
| OA (1) | OA12101A (ru) |
| PA (1) | PA8507801A1 (ru) |
| PE (1) | PE20020157A1 (ru) |
| PL (1) | PL356062A1 (ru) |
| SK (1) | SK7602002A3 (ru) |
| UY (1) | UY26465A1 (ru) |
| WO (1) | WO2001040189A1 (ru) |
| YU (1) | YU40002A (ru) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0400624A2 (hu) | 1998-04-30 | 2004-06-28 | Agouron Pharmaceuticals, Inc. | Picornavírus-ellenes vegyületek, előállításuk és alkalmazásuk |
| PE20011277A1 (es) | 2000-04-14 | 2002-01-07 | Agouron Pharma | Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis |
| MXPA02012456A (es) * | 2000-06-14 | 2004-01-26 | Agouron Pharma | Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y materiales para su sintesis. |
| KR20030070082A (ko) * | 2000-12-28 | 2003-08-27 | 시오노기세이야쿠가부시키가이샤 | 칸나비노이드 2형 수용체 친화 작용을 갖는 피리돈 유도체 |
| AU2003243657A1 (en) * | 2002-06-26 | 2004-01-19 | Bristol-Myers Squibb Company | Amino-bicyclic pyrazinones and pyridinones |
| EP1606019A1 (en) * | 2003-03-07 | 2005-12-21 | The University Court of The University of Aberdeen | Cannabinoid receptor inverse agonists and neutral antagonists as therapeutic agents for the treatment of bone disorders |
| WO2004093860A1 (en) * | 2003-04-21 | 2004-11-04 | Pfizer Inc. | Inhibitors of sars related coronavirus proteinase |
| US20040235952A1 (en) * | 2003-05-05 | 2004-11-25 | Agouron Pharmaceuticals, Inc. | Inhibitors of severe acute respiratory syndrome (SARS) 3C-like proteinase |
| US7462594B2 (en) * | 2003-12-31 | 2008-12-09 | Taigen Biotechnology Co., Ltd. | Peptide-like compounds that inhibit coronaviral 3CL and flaviviridae viral proteases |
| AU2004312547A1 (en) * | 2003-12-31 | 2005-07-21 | Taigen Biotechnology | Protease inhibitors |
| US7087622B2 (en) | 2004-05-07 | 2006-08-08 | Janssen Pharmaceutica N.V. | Pyridone compounds as inhibitors of bacterial type III protein secreation systems |
| GB0702862D0 (en) * | 2007-02-14 | 2007-03-28 | Univ Aberdeen | Therapeutic compounds |
| KR100891699B1 (ko) | 2007-04-10 | 2009-04-03 | 광주과학기술원 | 7-아미노-4-((ｓ)-3-(4-플루오로페닐)-2-((r)-3-메틸-2-(5-메틸이소옥사졸-3-카복사미도)부탄아미도)프로판아미도)-7-옥소-2-헵테노에이트 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 바이러스성 질환의 예방 및 치료용 약학적 조성물 |
| US8795630B2 (en) * | 2008-08-29 | 2014-08-05 | Treventis Corporation | Butyrylcholinesterase ligands as diagnostic tools and treatment for diseases of the nervous system |
| KR101385855B1 (ko) * | 2012-10-16 | 2014-04-22 | 이동익 | 카뎁신 검출용 다이아로마틱 아미노산 기질 |
| WO2017197377A1 (en) * | 2016-05-13 | 2017-11-16 | Emory University | Peptidomimetics for the treatment of norovirus infection |
| US11124497B1 (en) | 2020-04-17 | 2021-09-21 | Pardes Biosciences, Inc. | Inhibitors of cysteine proteases and methods of use thereof |
| US11174231B1 (en) | 2020-06-09 | 2021-11-16 | Pardes Biosciences, Inc. | Inhibitors of cysteine proteases and methods of use thereof |
| US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4652676A (en) | 1985-05-06 | 1987-03-24 | General Foods Corporation | L-aminodicarboxylic acid alkenes |
| US5374623A (en) | 1992-08-20 | 1994-12-20 | Prototek, Inc. | Cysteine protease inhibitors effective for in vivo use |
| US5514778A (en) | 1993-07-01 | 1996-05-07 | Eli Lilly And Company | Anti-picornaviral agents |
| US5486623A (en) | 1993-12-08 | 1996-01-23 | Prototek, Inc. | Cysteine protease inhibitors containing heterocyclic leaving groups |
| IL112759A0 (en) | 1994-02-25 | 1995-05-26 | Khepri Pharmaceuticals Inc | Novel cysteine protease inhibitors |
| IT1269511B (it) | 1994-05-17 | 1997-04-01 | Univ Degli Studi Milano | Derivati di acidi ammino-solfonici , loro impiego nella sintesi di pseudopeptidi e procedimento per la loro preparazione |
| US5498616A (en) | 1994-11-04 | 1996-03-12 | Cephalon, Inc. | Cysteine protease and serine protease inhibitors |
| WO1996030395A2 (en) | 1995-03-31 | 1996-10-03 | Takeda Chemical Industries, Ltd. | Cysteine protease inhibitor |
| IT1281031B1 (it) | 1995-11-17 | 1998-02-11 | Carlo Chiaves | Struttura prefabbricata per la realizzazione di opere costruite a cielo aperto, particolarmente per cavalcavia autostradali, |
| ES2242225T3 (es) | 1996-05-14 | 2005-11-01 | Agouron Pharmaceuticals, Inc. | Inhibidores de proteasas 3c antipicornavirales y procedimientos correspondientes de utilizacion y de preparacion. |
| US5856530A (en) | 1996-05-14 | 1999-01-05 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds and methods for their use and preparation |
| WO1997049668A1 (en) | 1996-06-13 | 1997-12-31 | Smithkline Beecham Corporation | Inhibitiors of cysteine protease |
| US6020371A (en) | 1997-03-28 | 2000-02-01 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds compositions containing them and methods for their use |
| PT975588E (pt) | 1997-03-28 | 2004-02-27 | Agouron Pharma | Compostos antipicornavirais, composicoes que os contem e metodos para a sua utilizacao |
| US6331554B1 (en) | 1997-03-28 | 2001-12-18 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds, compositions containing them, and methods for their use |
| US5962487A (en) | 1997-12-16 | 1999-10-05 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds and methods for their use and preparation |
| HUP0400624A2 (hu) * | 1998-04-30 | 2004-06-28 | Agouron Pharmaceuticals, Inc. | Picornavírus-ellenes vegyületek, előállításuk és alkalmazásuk |
| US6369226B1 (en) | 1999-06-21 | 2002-04-09 | Agouron Pharmaceuticals, Inc. | Substituted benzamide inhibitors of rhinovirus 3C protease |
| CN1372566A (zh) | 1999-08-04 | 2002-10-02 | 阿格罗尼制药公司 | 抗细小核糖核酸病毒的化合物和组合物,它们的药物用途,及其合成原料 |
| PE20010517A1 (es) | 1999-08-24 | 2001-05-16 | Agouron Pharma | Las rutas sinteticas eficientes para la preparacion de los inhibidores de la proteasa del rinovirus y los intermedios claves |
| EP1206470A2 (en) | 1999-08-24 | 2002-05-22 | Agouron Pharmaceuticals, Inc. | Processes and intermediates for the preparation of isoxazolecarboxamides and analogues |
-
2000
- 2000-11-30 PA PA20008507801A patent/PA8507801A1/es unknown
- 2000-11-30 PE PE2000001276A patent/PE20020157A1/es not_active Application Discontinuation
- 2000-12-01 JP JP2001541874A patent/JP2003515591A/ja not_active Withdrawn
- 2000-12-01 CN CN00816602A patent/CN1402710A/zh active Pending
- 2000-12-01 AU AU18094/01A patent/AU777943B2/en not_active Ceased
- 2000-12-01 YU YU40002A patent/YU40002A/sh unknown
- 2000-12-01 EA EA200200625A patent/EA200200625A1/ru unknown
- 2000-12-01 CZ CZ20021906A patent/CZ20021906A3/cs unknown
- 2000-12-01 US US09/726,376 patent/US6514997B2/en not_active Expired - Fee Related
- 2000-12-01 NZ NZ518934A patent/NZ518934A/en unknown
- 2000-12-01 AP APAP/P/2002/002510A patent/AP2002002510A0/en unknown
- 2000-12-01 MX MXPA02005124A patent/MXPA02005124A/es not_active Application Discontinuation
- 2000-12-01 OA OA1200200160A patent/OA12101A/en unknown
- 2000-12-01 PL PL00356062A patent/PL356062A1/xx not_active Application Discontinuation
- 2000-12-01 WO PCT/US2000/032621 patent/WO2001040189A1/en not_active Application Discontinuation
- 2000-12-01 UY UY26465A patent/UY26465A1/es not_active Application Discontinuation
- 2000-12-01 BR BR0016742-8A patent/BR0016742A/pt not_active IP Right Cessation
- 2000-12-01 DO DO2000000108A patent/DOP2000000108A/es unknown
- 2000-12-01 HU HU0204006A patent/HUP0204006A3/hu unknown
- 2000-12-01 EP EP00980893A patent/EP1252145A1/en not_active Withdrawn
- 2000-12-01 KR KR1020027007099A patent/KR20020058076A/ko not_active Application Discontinuation
- 2000-12-01 SK SK760-2002A patent/SK7602002A3/sk unknown
- 2000-12-01 EE EEP200200281A patent/EE200200281A/xx unknown
- 2000-12-01 IL IL14942700A patent/IL149427A0/xx unknown
- 2000-12-01 CA CA002392504A patent/CA2392504A1/en not_active Abandoned
- 2000-12-04 CO CO00092264A patent/CO5261566A1/es not_active Application Discontinuation
- 2000-12-04 AR ARP000106412A patent/AR030540A1/es unknown
-
2002
- 2002-05-10 IS IS6378A patent/IS6378A/is unknown
- 2002-05-30 BG BG106754A patent/BG106754A/bg unknown
- 2002-05-31 NO NO20022589A patent/NO20022589L/no unknown
-
2003
- 2003-07-09 HK HK03104911.5A patent/HK1052933A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0204006A2 (hu) | 2003-03-28 |
| YU40002A (sh) | 2006-01-16 |
| PA8507801A1 (es) | 2002-08-26 |
| AU1809401A (en) | 2001-06-12 |
| BG106754A (bg) | 2003-07-31 |
| KR20020058076A (ko) | 2002-07-12 |
| BR0016742A (pt) | 2002-09-03 |
| WO2001040189A1 (en) | 2001-06-07 |
| NO20022589L (no) | 2002-07-31 |
| HUP0204006A3 (en) | 2004-11-29 |
| HK1052933A1 (zh) | 2003-10-03 |
| CA2392504A1 (en) | 2001-06-07 |
| US20010047006A1 (en) | 2001-11-29 |
| MXPA02005124A (es) | 2003-01-28 |
| NZ518934A (en) | 2003-11-28 |
| AP2002002510A0 (en) | 2002-06-30 |
| EA200200625A1 (ru) | 2002-12-26 |
| EP1252145A1 (en) | 2002-10-30 |
| CO5261566A1 (es) | 2003-03-31 |
| EE200200281A (et) | 2003-06-16 |
| CN1402710A (zh) | 2003-03-12 |
| CZ20021906A3 (cs) | 2003-02-12 |
| SK7602002A3 (en) | 2003-02-04 |
| PL356062A1 (en) | 2004-06-14 |
| IS6378A (is) | 2002-05-10 |
| JP2003515591A (ja) | 2003-05-07 |
| IL149427A0 (en) | 2002-11-10 |
| UY26465A1 (es) | 2001-06-29 |
| PE20020157A1 (es) | 2002-02-22 |
| US6514997B2 (en) | 2003-02-04 |
| NO20022589D0 (no) | 2002-05-31 |
| AU777943B2 (en) | 2004-11-04 |
| DOP2000000108A (es) | 2003-03-15 |
| AR030540A1 (es) | 2003-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| OA12101A (en) | Antipicornaviral compounds and compositions, theirpharmaceutical uses, and materials for their synt hesis. | |
| JP4212358B2 (ja) | Ｖｌａ−４阻害薬 | |
| TW201823208A (zh) | N－醯基胺基酸化合物及其使用方法 | |
| EP1073672B1 (en) | Antipicornaviral compounds, their preparation and use | |
| WO1998018794A1 (fr) | Nouveaux composes d'amide heterocycliques et leur utilisation a des fins medicinales | |
| AU2014346919A1 (en) | Compositions and methods for modulating Farnesoid X receptors | |
| KR20050071472A (ko) | 퀴놀린 항생 물질 중간체의 제조 방법 | |
| CN114728168A (zh) | 三唑氨基甲酸酯吡啶基磺酰胺作为lpa受体拮抗剂及其用途 | |
| US20230271973A1 (en) | Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists | |
| KR20230019881A (ko) | Lpa 수용체 길항제 및 이의 용도 | |
| JPWO2005121135A1 (ja) | Ｖｌａ−４阻害薬 | |
| KR20220141331A (ko) | P2x3 조정제 | |
| TWI820266B (zh) | 巨環化合物及其用途 | |
| ES2492694T3 (es) | Nuevos compuestos espiroheterocíclicos como antagonistas de mGlu5 | |
| CN101641341A (zh) | 酰胺化合物及其作为抗肿瘤剂的用途 | |
| TWI838626B (zh) | Lpa受體拮抗劑及其用途 | |
| JP7427665B2 (ja) | 関節損傷を治療するための軟骨形成を誘導するための６－ヒドロキシ－８－オキサトリシクロ［３．２．１．０２，４］オクタン－２－カルボキサミド誘導体 | |
| TW202200565A (zh) | 抗病毒性1,3-二氧代茚化合物 | |
| TW202300144A (zh) | 抗病毒雜環化合物 | |
| CZ20003986A3 (cs) | Antipicornavirální součeniny a kompozice, jejich farmaceutické použití a materiály pro jejich syntézu |